110 related articles for article (PubMed ID: 7923299)
1. Inhibitory effects of nicorandil on sympathetic coronary vasoconstriction.
Chujo M; Mori H; Tanaka E; Nakazawa H; Okino H
Cardiovasc Res; 1994 Jun; 28(6):917-22. PubMed ID: 7923299
[TBL] [Abstract][Full Text] [Related]
2. Coronary vasoconstrictive effects of neuropeptide Y and their modulation by the ATP-sensitive potassium channel in anesthetized dogs.
Tanaka E; Mori H; Chujo M; Yamakawa A; Mohammed MU; Shinozaki Y; Tobita K; Sekka T; Ito K; Nakazawa H
J Am Coll Cardiol; 1997 May; 29(6):1380-9. PubMed ID: 9137239
[TBL] [Abstract][Full Text] [Related]
3. Intense sympathetic stimulation releases neuropeptide Y but fails to evoke sustained coronary vasoconstriction in dogs.
Otani N; Yang T; Levy MN
Circ Res; 1993 Apr; 72(4):816-26. PubMed ID: 8443869
[TBL] [Abstract][Full Text] [Related]
4. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
Pernow J; Lundberg JM
Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
Lundberg JM; Modin A
Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
Pernow J; Kahan T; Hjemdahl P; Lundberg JM
Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
[TBL] [Abstract][Full Text] [Related]
7. Time-dependent effects of ischaemia on neuropeptide Y mechanisms in pig renal vascular control in vivo.
Malmström RE; Lundberg JM
Acta Physiol Scand; 1997 Nov; 161(3):327-38. PubMed ID: 9401585
[TBL] [Abstract][Full Text] [Related]
8. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
Malmström RE; Lundberg JN; Weitzberg E
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
[TBL] [Abstract][Full Text] [Related]
9. Sympathetic vascular control of the pig nasal mucosa (III): Co-release of noradrenaline and neuropeptide Y.
Lacroix JS; Stjärne P; Anggärd A; Lundberg JM
Acta Physiol Scand; 1989 Jan; 135(1):17-28. PubMed ID: 2911948
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y and reserpine-resistant vasoconstriction evoked by sympathetic nerve stimulation in the dog skeletal muscle.
Pernow J; Kahan T; Lundberg JM
Br J Pharmacol; 1988 Jul; 94(3):952-60. PubMed ID: 3179619
[TBL] [Abstract][Full Text] [Related]
11. Modulation of adrenergic coronary vasoconstriction via ATP-sensitive potassium channel.
Mori H; Chujo M; Tanaka E; Yamakawa A; Shinozaki Y; Mohamed MU; Nakazawa H
Am J Physiol; 1995 Mar; 268(3 Pt 2):H1077-85. PubMed ID: 7900861
[TBL] [Abstract][Full Text] [Related]
12. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
Modin A
Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
[TBL] [Abstract][Full Text] [Related]
13. Sympathetic stimulation-evoked overflow of norepinephrine and neuropeptide Y from the heart.
Warner MR; Senanayake PD; Ferrario CM; Levy MN
Circ Res; 1991 Aug; 69(2):455-65. PubMed ID: 1776971
[TBL] [Abstract][Full Text] [Related]
14. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo.
Kamijo T; Iwai T; Haruta K; Takeda K
Arch Int Pharmacodyn Ther; 1996; 331(3):273-84. PubMed ID: 9124999
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y and differential sympathetic control of splenic blood flow and capacitance function in the pig and dog.
Modin A; Pernow J; Lundberg JM
Acta Physiol Scand; 1993 Jan; 147(1):15-25. PubMed ID: 8095766
[TBL] [Abstract][Full Text] [Related]
16. Potency and receptors involved in coronary vasoconstriction caused by neuropeptide Y(NPY).
Aizawa Y; Satoh M; Aizawa M; Funazaki T; Niwano S; Miyajima S; Shibata A
Jpn Heart J; 1987 Nov; 28(6):891-8. PubMed ID: 2832630
[TBL] [Abstract][Full Text] [Related]
17. Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction.
Han S; Yang CL; Chen X; Naes L; Cox BF; Westfall T
Am J Physiol; 1998 Jan; 274(1):H290-4. PubMed ID: 9458879
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y and control of vascular resistance in skeletal muscle.
Revington M; McCloskey DI
Regul Pept; 1988 Dec; 23(3):331-42. PubMed ID: 3238054
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of nitric oxide synthesis augments centrally induced sympathetic coronary vasoconstriction in cats.
Goodson AR; Leibold JM; Gutterman DD
Am J Physiol; 1994 Oct; 267(4 Pt 2):H1272-8. PubMed ID: 7943371
[TBL] [Abstract][Full Text] [Related]
20. Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man.
Clarke J; Benjamin N; Larkin S; Webb D; Maseri A; Davies G
Circulation; 1991 Mar; 83(3):774-7. PubMed ID: 1999028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
